As of Aug 03
| +0.04 / +0.44%|
The 2 analysts offering 12-month price forecasts for SciClone Pharmaceuticals Inc have a median target of 11.25, with a high estimate of 15.00 and a low estimate of 7.50. The median estimate represents a +22.95% increase from the last price of 9.15.
The current consensus among 2 polled investment analysts is to Buy stock in SciClone Pharmaceuticals Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.